Dr. Gelbard is a board certified Otolaryngologist at Vanderbilt University in Nashville Tennessee specializing in adult laryngeal and tracheal disease. He completed his undergraduate education at Stanford University, medical school atTulane School of Medicine, and internshipand residency at the Baylor College of Medicine in Houston Texas.Dr.Gelbard completed a postdoctoral research fellowship in Immunology at the MD Anderson Cancer Center as well as a clinicalfellowship in Laryngeal Surgery at Vanderbilt School of Medicine. Hehas authored numerous peer-reviewed articles and book chapters and lectures internationally on adult airway disease. He currently is Co-director of the Vanderbilt Center for Complex Airway Reconstruction (AeroVU). Additionally, he is aNIH-funded principle investigator studying the immunologic mechanisms underlying benign laryngeal and tracheal disease. He is also PI of anexternally funded prospective multi-institutional study of idiopathic subglottic stenosis (iSGS) andmanaging director of the North American Airway Collaborative (NoAAC). NoAAC is a funded, multi-institutional consortium with 40 participating centers in the United States and Europe that works to exchange information concerning the treatment of adult airway disease. It is composed ofoutstanding collaborators who pursue a unique combination of genetic, molecular, and epidemiologic based approaches to investigate the critical factors underlying the pathogenesis and outcomes of laryngotracheal stenosis.